1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > IMS Country Review 2016: USA

IMS Country Review 2016: USA

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: USA
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 5
PRICING SYSTEM 5
REGULATORY ENVIRONMENT 5
INDUSTRY ENVIRONMENT 5
CHANNELS OF DISTRIBUTION 11
UNITED STATES DATA COLLECTION 12
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 13
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 13
FIGURE 2: AUDITED MARKET TREND 14
FIGURE 3: LEADING 35 LOCAL COMPANIES 15
FIGURE 4: LEADING 35 CORPORATIONS 17
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 19
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 20
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 21
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 22
FIGURE 8: A10C HUMAN INSULIN+ANALOGUES 22
FIGURE 9: A10J BIGUANIDE ANTIDIABETICS 23
FIGURE 10: A10P SGLT2 INHIBITOR A-DIABS 24
FIGURE 11: C10A CHOLESTandTRIGLY.REGULATOR 25
FIGURE 12: D1A ANTIFUNGALS DERMATOLOGCL 26
FIGURE 13: J5B ANTIVIRALS EXCL ANTI-HIV 27
FIGURE 14: J5C HIV ANTIVIRALS 28
FIGURE 15: L1G MAB ANTINEOPLASTICS 29
FIGURE 16: L1H PROTEIN KINASE INH A-NEO 30
FIGURE 17: L3A IMMUNOSTIM AG EX INTFRON 31
FIGURE 18: L4B ANTI-TNF PRODUCTS 32
FIGURE 19: N3A ANTI-EPILEPTICS 33
FIGURE 20: N5A ANTIPSYCHOTICS 34
FIGURE 21: P1D ANTI-MALARIALS 35
FIGURE 22: R7X ALL OTH RESP SYST PRODS 36
FIGURE 23: LEADING 40 PRODUCTS 37
FIGURE 24: LEADING 40 NEW PRODUCTS 39
FIGURE 25: LEADING 15 PRODUCT FORMS 42
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 43
SECTION 3: APPENDICES 45
APPENDIX 1: AUDITED UNIVERSE 45
APPENDIX 2: COUNTRY SPECIFIC ALERTS 46
APPENDIX 3: MEASURE INDEX 49
APPENDIX 4: SALES DATA MEASURES 51
APPENDIX 5: *LATEST FACTORS 53
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 57
APPENDIX 7: CORPORATIONS 59
APPENDIX 8: PRODUCT NAMES 60
APPENDIX 9: THERAPIES 62
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 63
IMS Country R

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...


Download Unlimited Documents from Trusted Public Sources

Hospital Industry in the Netherlands

  • January 2017
    13 pages
  • Hospital  

    Digestive Syste...  

    Computed Tomogr...  

  • Netherlands  

View report >

Nursing Home Forecast Statistics in Australia

  • January 2017
    37 pages
  • Nursing Home  

    Hospital  

    Pension  

  • Australia  

View report >

Nursing Home Industry

  • January 2017
    14 pages
  • Nursing Home  

View report >

Related Market Segments :

Hospital

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.